J Biol Chem. 2021 Aug 17. pii: S0021-9258(21)00891-7. [Epub ahead of print]
101088
The phosphatase and tensin homolog deleted on chromosome ten (PTEN) protein is a key player in tumorigenesis of non-small cell lung cancer, and was recently found to be inactivated by TRIM25-mediated K63-linked polyubiquitination. However, the deubiquitinase coordinates TRIM25 in PTEN ubiquitination is still elusive. In the present study, we found that this K63-linked polyubiquitination could be ablated by the ubiquitin-specific protease 10 (USP10) in a screen against a panel of deubiquitinases. We found using co-immununoprecipitation/immunoblotting that USP10 interacted with PTEN and reduced the K63-linked polyubiquitination of PTEN mediated by TRIM25 in non-small cell lung cancer (NSCLC) cells. Moreover, USP10, but not its inactive C424A deubiquitinating mutant or other deubiquitinases, abolished PTEN from K63-linked polyubiquitination mediated by TRIM25. In contrast to TRIM25, USP10 restored PTEN phosphatase activity and reduced the production of the secondary messenger PI(3,4,5)P3, thereby inhibiting AKT/mTOR pro-growth signaling transduction in NSCLC cells. Moreover, USP10 was downregulated in NSCLC cell lines and primary tissues, whereas TRIM25 was upregulated. Consistent with its molecular activity, re-expression of USP10 suppressed NSCLC cell proliferation and migration while knockout of USP10 promoted NSCLC cell proliferation and migration. In conclusion, the present study demonstrates that USP10 coordinates TRIM25 to modulate PTEN activity. Specifically, USP10 activates PTEN by preventing its K63-linked polyubiquitination mediated by TRIM25 and suppresses the AKT/mTOR signaling pathway thereby inhibiting NSCLC proliferation, indicating that it may be a potential drug target for cancer treatment.
Keywords: K63-linked polyubiquitination; NSCLC; PTEN; USP10; deubiquitinase